World's Best Scientists 2026 revealed!
Maurizio Zazzi

Maurizio Zazzi

D-Index & Metrics

Microbiology

D-Index
47
Citations
8805
World Ranking
4779
National Ranking
153

Overview

Maurizio Zazzi is affiliated with the University of Siena in Italy. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with specific focus on subfields such as Infectious Diseases, Virology, Epidemiology, Public Health, Environmental and Occupational Health, and Hepatology.

The scientist's publications concentrate on topics including HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Hepatitis C virus research, and Pneumocystis jirovecii pneumonia detection and treatment.

Notable recent papers include:

  • SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 (2021), published in Expert Opinion on Therapeutic Patents
  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge (2020), published in Molecules
  • Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort (2022), published in Clinical Infectious Diseases
  • Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic (2020), published in Viruses
  • Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry (2020), published in Open Forum Infectious Diseases

The researcher collaborates frequently with others including Ilaria Vicenti, Francesco Saladini, Filippo Dragoni, Maria Mercedes Santoro, and Antonella Castagna.

Common publication venues for their work are:

  • Journal of Antimicrobial Chemotherapy
  • Viruses
  • Preprints.org
  • Open Forum Infectious Diseases
  • Journal of Infection

Best Publications

  • Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

    Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • A novel methodology for large-scale phylogeny partition

    Mattia C.F. Prosperi;Massimo Ciccozzi;Iuri Fanti;Francesco Saladini

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.

    Giulietta Venturi;Marinunzia Catucci;Laura Romano;Paola Corsi

  • Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.

    Annalaura Brai;Roberta Fazi;Cristina Tintori;Claudio Zamperini

  • Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models

    Mattia C. F. Prosperi;Mattia C. F. Prosperi;Michal Rosen-Zvi;André Altmann;Maurizio Zazzi

  • SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19

    Ilaria Vicenti;Maurizio Zazzi;Francesco Saladini

  • The development of artificial neural networks to predict virological response to combination HIV therapy.

    Brendan Larder;Dechao Wang;Andrew Revell;Julio Montaner

  • Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens

    A. Marconi;M. Balestrieri;G. Comastri;F.R. Pulvirenti

  • A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

    Dechao Wang;Brendan Larder;Andrew Revell;Julio Montaner

  • Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort

    Unknown

  • Clinically validated genotype analysis: guiding principles and statistical concerns.

    Françoise Brun-Vézinet;Dominique Costagliola;Mounir Ait Khaled;Vincent Calvez

  • Selecting anti-HIV therapies based on a variety of genomic and clinical factors

    Michal Rosen-Zvi;Andre Altmann;Mattia Prosperi;Ehud Aharoni

  • Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time

    Dineke Frentz;Charles A. B. Boucher;Charles A. B. Boucher;Matthias Assel;Andrea De Luca

  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.

    Francesca Picarazzi;Ilaria Vicenti;Francesco Saladini;Maurizio Zazzi

  • Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.

    Roberta Gagliardini;Arturo Ciccullo;Alberto Borghetti;Franco Maggiolo

  • Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

    Andrea De Luca;Andrea De Luca;David Dunn;Maurizio Zazzi;Ricardo Camacho

  • Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.

    André Altmann;Michal Rosen-Zvi;Mattia Prosperi;Ehud Aharoni

Frequent Co-Authors

Andrea De Luca
Andrea De Luca University of Siena
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Rolf Kaiser
Rolf Kaiser University of Cologne
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
Claudia Balotta
Claudia Balotta University of Milan
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Francesca Ceccherini-Silberstein
Francesca Ceccherini-Silberstein University of Rome Tor Vergata
Carlo Federico Perno
Carlo Federico Perno University of Milan
Fausto Baldanti
Fausto Baldanti University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing a degree in Microbiology in the USA, exploring related online degrees can broaden career opportunities. One growing field is health information management, which blends healthcare and data management. If you’re interested, consider exploring health information management jobs salary insights to understand potential earnings and growth.

Choosing the right program is crucial, especially for online learning. Accreditation matters, and programs accredited by CAHIIM ensure quality education. You can find the top options by checking out accredited online health information management degree cahiim listings.

If you want to enter the healthcare field quickly, certifications like medical billing and coding are excellent paths. Many institutions offer fast online medical billing and coding certification programs that can be completed in months, opening doors to administrative roles in healthcare.

Moreover, numerous medical degrees are now available online, expanding access to health-related careers. If you're curious about the options, it’s helpful to review what medical degree can i get online to find a program that aligns with your goals.

Best Scientists Citing Maurizio Zazzi

Trending Scientists